Surgery-like brain radiation for up to 5 metastases
Part of Brain & nervous system, Cancer clinical trials.
This trial compares two ways of giving focused radiation to the brain for people with a limited number of brain metastases. It aims to see which schedule works best (and is likely best for costs and quality of life).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- Your overall health (performance status) must be 0 or 1, meaning you’re able to do most daily activities
- You have up to 5 brain metastases from certain cancers (kidney cancer, sarcoma, melanoma, or some lung, breast, or GI cancers), confirmed by biopsy or surgery
- The largest brain spots must be within about 10–25 mm, and the total treatment size must be limited (max cumulative volume 30 cm3)
- You need normal blood counts and cannot have certain high-risk brain findings like bleeding metastases or cancer spread to the brain lining
- You must be able to do brain MRI scans with contrast, use a mask during treatment, and agree to birth control if you can get pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving powerful, precise radiation (stereotactic radiosurgery) to large brain tumors before surgery, then using more radiation after surgery. It aims to see if this approach can control the tumor better while reducing side effects.
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
This study tests a more targeted form of stereotactic (precise) brain radiation for people with brain metastases from large cell cancer. It aims to improve the balance between effectiveness and side effects by carefully focusing where the radiation goes.
This study tests a type of radiation treatment for people with one or more brain tumors that are larger than usual (2 to 5 centimeters). It aims to see if this approach is safe and effective, and may be an option if you are not having immediate surgery.
Hear when a new Brain Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.